Meet the Investors

Maurits Brandt | Senior Associate | Novo Holdings

Maurits Brandt is a Senior Associate at Novo Holdings in Copenhagen active in the Seed Investments team since 2022. In this role he’s actively scouting for innovative ideas to develop new therapeutics or platforms around which new therapeutic companies can be created. Prior to his role in Novo Holdings, he was a business developer at ProQR Therapeutics and has been Senior Analyst for several years at Aescap, a biotech focused Public Equity investor based in Amsterdam. Maurits holds an MSc in Biochemistry from Leiden University.

About Novo Holdings

Novo Holdings is an evergreen life sciences investment company with 100 billion+ USD assets under management. The Seed Investments team within Novo Holdings provides capital, network and know-how to transform promising life-science discoveries into successful biotech startups in the therapeutics space. Seed Investments focuses on company creation, building biotech startups and aims to develop strong and competitive companies that can be financed all the way to a commercial exit.